Foundation Healthcare (FDNH) 10-Q 15 May 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2014	15-May-14
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Trading Symbol	'FDNH	'
Entity Registrant Name	'FOUNDATION HEALTHCARE, INC.	'
Entity Central Index Key	'0001272597	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	171,247,581

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2014	Dec. 31, 2013
ASSETS	'	'
Cash and cash equivalents	$3,958,742	$4,212,076
Accounts receivable, net of allowances for doubtful accounts of $2,536,980 and $4,778,915, respectively	12,655,299	12,755,642
Receivables from affiliates	854,987	848,002
Supplies inventories	1,940,870	1,931,142
Prepaid and other current assets	4,805,921	4,302,885
Current assets from discontinued operations	199,032	518,629
Total current assets	24,414,851	24,568,376
Property and equipment, net	11,479,697	12,073,986
Equity method investments in affiliates	5,600,880	5,699,093
Intangible assets, net	10,624,754	11,138,621
Goodwill	973,927	973,927
Other assets	226,784	244,598
Other assets from discontinued operations	513,379	576,228
Total assets	53,834,272	55,274,829
Liabilities:	'	'
Accounts payable	10,627,288	11,648,987
Accrued liabilities	5,148,921	4,114,915
Preferred noncontrolling interests dividends payable	121,878	195,411
Short term debt	6,183,610	5,664,827
Current portion of long-term debt	10,592,445	7,919,179
Other current liabilities	3,031,628	4,391,587
Current liabilities from discontinued operations	5,507,982	5,620,697
Total current liabilities	41,213,752	39,555,603
Long-term debt, net of current portion	5,988,737	10,031,732
Other liabilities	15,112,635	12,255,809
Other liabilities from discontinued operations	'	9,969
Total liabilities	62,315,124	61,853,113
Preferred noncontrolling interest	8,700,000	8,700,000
Commitments and contingencies (Note 9)	'	'
Foundation Healthcare shareholders' deficit:	'	'
Preferred stock $0.0001 par value, 10,000,000 authorized; no shares issued and outstanding	'	'
Common stock $0.0001 par value, 500,000,000 shares authorized; 171,323,381 and 163,834,886 issued and outstanding, respectively	17,132	16,383
Paid-in capital	18,759,152	18,241,756
Accumulated deficit	-37,066,821	-35,171,315
Total Foundation Healthcare shareholders' deficit	-18,290,537	-16,913,176
Noncontrolling interests	1,109,685	1,634,892
Total deficit	-17,180,852	-15,278,284
Total liabilities, preferred noncontrolling interest and shareholders' deficit	$53,834,272	$55,274,829

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Statement Of Financial Position [Abstract]	'	'
Accounts receivable, allowances for doubtful accounts	$2,536,980	$4,778,915
Preferred stock, par value	$0.00	$0.00
Preferred stock, authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	500,000,000	500,000,000
Common stock, issued	171,323,381	163,834,886
Common stock, outstanding	171,323,381	163,834,886

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Net Revenues:	'	'
Patient services	$19,513,483	$15,860,660
Management fees from affiliates	1,269,306	1,738,228
Equity in earnings of affiliates	527,083	1,216,715
Other revenue	1,118,326	474,889
Provision for doubtful accounts	-361,517	-636,851
Revenues	22,066,681	18,653,641
Operating Expenses:	'	'
Salaries and benefits	7,977,419	6,338,097
Supplies	4,941,370	4,500,940
Other operating expenses	9,042,701	7,756,021
Depreciation and amortization	1,466,268	1,116,687
Total operating expenses	23,427,758	19,711,745
Other Income (Expense):	'	'
Interest expense, net	-496,121	-466,669
Other income	'	93,007
Net other (expense)	-496,121	-373,662
Income (loss) from continuing operations, before taxes	-1,857,198	-1,431,766
Benefit for income taxes	852,005	'
Income (loss) from continuing operations, net of taxes	-1,005,193	-1,431,766
Loss from discontinued operations, net of tax	-312,323	'
Net income (loss)	-1,317,516	-1,431,766
Less: Net income attributable to noncontrolling interests	384,921	-1,092,031
Net income (loss) attributable to Foundation Healthcare	-1,702,437	-339,735
Preferred noncontrolling interests dividends	-193,069	'
Net income (loss) attributable to Foundation Healthcare common stock	-1,895,506	-339,735
Earnings per common share (basic and diluted):	'	'
Net income (loss) attributable to continuing operations attributable to Foundation Healthcare common stock	($0.01)	$0
Loss from discontinued operations, net of tax	$0	'
Basic and diluted net income (loss) per share	($0.01)	$0
Weighted average number of common and diluted shares outstanding	167,329,517	162,523,276
Pro Forma	'	'
Other Income (Expense):	'	'
Benefit for income taxes	'	129,099
Net income (loss) attributable to Foundation Healthcare common stock	'	($210,636)
Earnings per common share (basic and diluted):	'	'
Basic and diluted net income (loss) per share	'	$0

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Operating activities:	'	'
Net income (loss)	($1,317,516)	($1,431,766)
Less: Loss from discontinued operations, net of tax	-312,323	'
Income (loss) from continuing operations	-1,005,193	-1,431,766
Adjustments to reconcile loss from continuing operations to net cash provided by (used in) operating activities:	'	'
Depreciation and amortization	1,466,268	1,116,687
Stock-based compensation, net of cashless vesting	518,145	'
Provision for doubtful accounts	361,517	636,851
Equity in earnings of affiliates	-527,083	-1,216,715
Changes in assets and liabilities -	'	'
Accounts receivable, net of provision for doubtful accounts	-261,174	-2,111,768
Receivables from affiliates	-6,985	-35,691
Supplies Inventories	-9,728	38,020
Prepaid and other current assets	-503,036	-246,902
Other assets	17,814	'
Accounts payable	-1,021,699	-1,437,536
Accrued liabilities	1,034,006	3,286,995
Other current liabilities	-1,359,959	30,000
Other liabilities	2,856,826	-3,905
Net cash provided by (used in) operating activities from continuing operations	1,559,719	-1,375,730
Net cash provided by operating activities from discontinued operations	76,726	'
Net cash provided by (used in) operating activities	1,636,445	-1,375,730
Investing activities:	'	'
Purchase of property and equipment	-358,112	-2,612,598
Distributions from affiliates	625,296	1,266,100
Net cash provided by (used in) investing activities from continuing operations	267,184	-1,346,498
Net cash provided by investing activities from discontinued operations	'	'
Net cash provided by (used in) investing activities	267,184	-1,346,498
Financing activities:	'	'
Debt proceeds	767,923	3,431,211
Debt payments	-1,618,869	-1,383,326
Preferred noncontrolling interests dividends	-266,602	-424,594
Distributions to noncontrolling interests	-910,128	-37,444
Distributions to member	'	-377,930
Net cash provided by (used in) financing activities from continuing operations	-2,027,676	1,207,917
Net cash (used in) financing activities from discontinued operations	-129,287	'
Net cash provided by (used in) financing activities	-2,156,963	1,207,917
Net change in cash and cash equivalents	-253,334	-1,514,311
Cash and cash equivalents at beginning of period	4,212,076	3,037,067
Cash and cash equivalents at end of period	3,958,742	1,522,756
Cash Paid for Interest and Income Taxes:	'	'
Interest expense	504,509	443,709
Interest expense, discontinued operations	62,234	'
Income taxes, continuing operations	$1,950,000	'

Nature_of_Business

Nature of Business	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Nature of Business	'
	Note 1 – Nature of Business
	Foundation Healthcare, Inc. (the “Company”) is organized under the laws of the state of Oklahoma and owns controlling and noncontrolling interests in surgical hospitals located in Texas. The Company also owns noncontrolling interests in ambulatory surgery centers (“ASCs”) located in Texas, Oklahoma, Pennsylvania, New Jersey, Maryland and Ohio. Additionally, the Company provides sleep testing management services to various rural hospitals in Iowa, Minnesota, Missouri, Nebraska and South Dakota under management contracts with the hospitals. The Company provides management services to a majority of the facilities that it has noncontrolling interests (referred to as “Affiliates”) under the terms of various management agreements.

Basis_of_Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Basis of Presentation	'
	Note 2 – Basis of Presentation
	Reverse Acquisition – On July 22, 2013, the Company acquired Foundation Surgery Affiliates, LLC (“FSA”) and FSA’s consolidated variable interest entity, Foundation Surgical Hospital Affiliates, LLC (“FSHA”) (collectively referred to as “Foundation”). For accounting purposes, the acquisition of FSA was accounted for as a reverse acquisition and as a result, the Company’s historical operating results included in the accompanying consolidated financial statements for the periods prior to July 22, 2013 represent those of FSA. The historical financial statements of FSA have been adjusted for the effect of the recapitalization that occurred as a result of the reverse acquisition.
	Going Concern and Management’s Plan – As of March 31, 2014, the Company had an accumulated deficit of $37.1 million and a working capital deficiency of $16.8 million. During the three months ended March 31, 2014, the Company generated a net loss attributable to Foundation Healthcare of $1.7 million and generated cash flow from operating activities from continuing operations of $1.6 million. As of March 31, 2014, the Company had cash and cash equivalents of $4.0 million. Management expects to refinance, by the end of the second quarter of 2014, a significant portion of the Company’s long-term debt obligations. Management expects that the Company will be able to significantly reduce its annual debt service payments as part of the refinancing; however, there is no assurance that management will be successful in completing the debt refinancing.
	If management is unable to refinance a significant portion of its existing debt as noted above, the Company may be forced to obtain extensions on existing debt obligations as they become due in 2014. Although management has historically been successful in obtaining extensions, there is no assurance that the Company’s lenders will continue to grant them in the future. In addition, management may choose to raise additional funds through the sale of equity or assets, but there is no assurance that the Company will be successful in completing such actions.
	If management does not complete the debt refinancing or alternatively obtain extensions on some of its debt obligations during 2014, the Company may not have sufficient cash on hand or generate sufficient cash flow from operations to meet its cash requirements over the next 12 months. These uncertainties raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	Note 3 – Summary of Significant Accounting Policies
	For a complete list of the Company’s significant accounting policies, please see the Company’s Annual Report on Form 10-K for the year ending December 31, 2013.
	Interim Financial Information – The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles for interim financial statements and in accordance with Regulation S-X. Accordingly, they do not include all of the information and
	footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2014 are not necessarily indicative of results that may be expected for the year ended December 31, 2014. The consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Form 10-K for the year ended December 31, 2013. The December 31, 2013 consolidated balance sheet was derived from audited financial statements.
	Pro forma income information – Prior to July 22, 2013, FSA’s and FSHA’s member had elected to have FSA’s and FSHA’s income taxed as an S Corporation under provisions of the Internal Revenue Code and a similar section of the state income tax law. Therefore, taxable income or loss is reported to the individual member for inclusion in its tax returns and no provision for income taxes is included in the Company’s consolidated financial statements for periods prior to July 22, 2013. The pro forma income information provides an adjustment for income tax expense as if FSA and FSHA had been a C Corporation prior to July 22, 2013 at an assumed combined federal and state effective tax rate of 38%, which approximates the calculated statutory tax rates for the periods.
	Consolidation – The accompanying consolidated financial statements include the accounts of the Company and its wholly owned, majority owned and controlled subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.
	The Company accounts for its investments in Affiliates in which the Company exhibits significant influence, but not control, in accordance with the equity method of accounting. The Company does not consolidate its equity method investments, but rather measures them at their initial costs and then subsequently adjusts their carrying values through income for their respective shares of the earnings or losses during the period. The Company monitors its investments for other-than-temporary impairment by considering factors such as current economic and market conditions and the operating performance of the companies and records reductions in carrying values when necessary.
	Use of estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
	Revenue recognition and accounts receivable – The Company recognizes revenues in the period in which services are performed. Accounts receivable primarily consist of amounts due from third-party payors and patients. The Company’s ability to collect outstanding receivables is critical to its results of operations and cash flows. Amounts the Company receives for treatment of patients covered by governmental programs such as Medicare and Medicaid and other third-party payors such as health maintenance organizations, preferred provider organizations and other private insurers are generally less than the Company’s established billing rates. Additionally, to provide for accounts receivable that could become uncollectible in the future, the Company establishes an allowance for doubtful accounts to reduce the carrying value of such receivables to their estimated net realizable value. Accordingly, the revenues and accounts receivable reported in the Company’s consolidated financial statements are recorded at the net amount expected to be received.
	Contractual Discounts and Cost Report Settlements – The Company derives a significant portion of its revenues from Medicare, Medicaid and other payors that receive discounts from its established billing rates. The Company must estimate the total amount of these discounts to prepare its consolidated financial statements. The Medicare and Medicaid regulations and various managed care contracts under which these discounts must be calculated are complex and are subject to interpretation and adjustment. The Company estimates the allowance for contractual discounts on a payor-specific basis given its interpretation of the applicable regulations or contract terms. These interpretations sometimes result in payments that differ from the Company’s estimates. Additionally, updated regulations and contract renegotiations occur frequently, necessitating regular review and assessment of the estimation process by management. Changes in estimates related to the allowance for contractual discounts affect revenues reported in the Company’s accompanying consolidated statements of operations.
	Cost report settlements under reimbursement agreements with Medicare and Medicaid are estimated and recorded in the period the related services are rendered and are adjusted in future periods as final settlements are determined. There is a reasonable possibility that recorded estimates will change by a material amount in the near term. There was no adjustment for estimated cost report settlements in the three month periods ended March 31, 2014 or 2013. The net cost report settlements due to the Company was approximately $235,000 and $235,000 at March 31, 2014 and December 31, 2013, respectively, and in included in prepaid and other current assets in the accompanying consolidated balance sheets. The Company’s management believes that adequate provisions have been made for adjustments that may result from final determination of amounts earned under these programs.
	Laws and regulations governing Medicare and Medicaid programs are complex and subject to interpretation. The Company believes that it is in compliance with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the Company’s financial statements. Compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties and exclusion from the Medicare and Medicaid programs.
	Provision and Allowance for Doubtful Accounts – To provide for accounts receivable that could become uncollectible in the future, the Company establishes an allowance for doubtful accounts to reduce the carrying value of such receivables to their estimated net realizable value. The primary uncertainty lies with uninsured patient receivables and deductibles, co-payments or other amounts due from individual patients.
	The Company has an established process to determine the adequacy of the allowance for doubtful accounts that relies on a number of analytical tools and benchmarks to arrive at a reasonable allowance. No single statistic or measurement determines the adequacy of the allowance for doubtful accounts. Some of the analytical tools that the Company utilizes include, but are not limited to, the aging of accounts receivable, historical cash collection experience, revenue trends by payor classification, revenue days in accounts receivable, the status of claims submitted to third party payors, reason codes for declined claims and an assessment of the Company’s ability to address the issue and resubmit the claim and whether a patient is on a payment plan and making payments consistent with that plan. Accounts receivable are written off after collection efforts have been followed in accordance with the Company’s policies. During the Company’s normal quarterly review process at March 31, 2014, management determined that a portion of the accounts receivable related to personal injury cases at our FSH SA location had grown to a level requiring it to be analyzed as a distinct payor category. Based on the historical cash collection experience and other analytical measures as noted above, the allowance for doubtful accounts related to the personal injury cases was lowered by $1.0 million.
	Due to the nature of the healthcare industry and the reimbursement environment in which the Company operates, certain estimates are required to record net revenues and accounts receivable at their net realizable values at the time products or services are provided. Inherent in these estimates is the risk that they will have to be revised or updated as additional information becomes available, which could have a material impact on the Company’s operating results and cash flows in subsequent periods. Specifically, the complexity of many third-party billing arrangements and the uncertainty of reimbursement amounts for certain services from certain payors may result in adjustments to amounts originally recorded.
	The patient and their third party insurance provider typically share in the payment for the Company’s products and services. The amount patients are responsible for includes co-payments, deductibles, and amounts not covered due to the provider being out-of-network. Due to uncertainties surrounding deductible levels and the number of out-of-network patients, the Company is not certain of the full amount of patient responsibility at the time of service. The Company estimates amounts due from patients prior to service and generally collects those amounts prior to service. Remaining amounts due from patients are then billed following completion of service.
	The activity in the allowance for doubtful accounts for the three months ending March 31, 2014 follows:
		2014
	Balance at beginning of period	$	4,778,915
	Provisions recognized as reduction in revenues		361,517
	Write-offs, net of recoveries		(2,603,452	)
	Balance at end of period	$	2,536,980
	Cash and cash equivalents – The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. Certificates of deposit with original maturities of more than three months are also considered cash equivalents if there are no restrictions on withdrawing funds from the account.
	Goodwill and Intangible Assets – The Company evaluates goodwill for impairment at least on an annual basis and more frequently if certain indicators are encountered. Goodwill is to be tested at the reporting unit level, defined as an ASC or hospital (referred to as a component), with the fair value of the reporting unit being compared to its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is not considered to be impaired. The Company will complete its annual impairment test in December 2014.
	Intangible assets other than goodwill which include physician membership interests, service contracts and covenants not to compete are amortized over their estimated useful lives using the straight line method. The remaining lives range from five to ten years. The Company evaluates the recoverability of identifiable intangible asset whenever events or changes in circumstances indicate that an intangible asset’s carrying amount may not be recoverable.
	Net income (loss) per share – Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted during the period. Dilutive securities having an anti-dilutive effect on diluted loss per share are excluded from the calculation.
	Recently Adopted and Recently Issued Accounting Guidance
	Adopted Guidance
	In February 2013, the FASB issued changes to the accounting for obligations resulting from joint and several liability arrangements. These changes require an entity to measure such obligations for which the total amount of the obligation is fixed at the reporting date as the sum of (i) the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors, and (ii) any additional amount the reporting entity expects to pay on behalf of its co-obligors. An entity will also be required to disclose the nature and amount of the obligation as well as other information about those obligations. Examples of obligations subject to these requirements are debt arrangements and settled litigation and judicial rulings. These changes become effective for the Company on January 1, 2014. Management has determined that the adoption of these changes did not have an impact on the Company’s consolidated financial statements, as the Company does not currently have any such arrangements.
	In July 2013, the FASB issued changes to the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. These changes require an entity to present an unrecognized tax benefit as a liability in the financial statements if (i) a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position, or (ii) the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset to settle any additional income taxes that would result from the disallowance of a tax position. Otherwise, an unrecognized tax benefit is required to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. Previously, there was diversity in practice as no explicit guidance existed. These changes become effective for the Company on January 1, 2014. Management has determined that the adoption of these changes did not have a significant impact on the Company’s consolidated financial statements.
	Issued Guidance
	In April 2014, the FASB issued changes to the reporting of discontinued operations and disclosures of disposals of components of an entity. The amendments change the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Additionally, the new guidance requires expanded disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income and expenses of discontinued operations. The amendments are effective prospectively for all disposals (or classifications as held for sale) of components of an entity, and for all businesses that, on acquisition, are classified as held for sale that occur within annual periods beginning on or after December 15, 2014, and interim periods within those years. The Company is currently evaluating the new guidance to determine the impact it may have to its consolidated financial statements.

Reverse_Acquisition

Reverse Acquisition	3 Months Ended
	Mar. 31, 2014
Business Combinations [Abstract]	'
Reverse Acquisition	'
	Note 4 – Reverse Acquisition
	On July 22, 2013, the Company acquired FSA and FSA’s consolidated variable interest entity, FSHA, from Foundation Healthcare Affiliates, LLC (“FHA”) pursuant to an Amended and Restated Membership Purchase Agreement (the “Purchase Agreement”). Pursuant to the Purchase Agreement, the Company (i) issued to FHA 114,500,000 shares of its common stock, (ii) issued to FHA a demand promissory note in the principal amount of $2.0 million, and (iii) assumed certain liabilities and obligations of FHA totaling approximately $2.0 million.
	For accounting purposes, the acquisition of FSA was accounted for as a reverse acquisition and as a result, the Company’s historical operating results included in the accompanying condensed consolidated financial statements for the periods prior to July 22, 2013 represent those of FSA. The historical financial statements of FSA have been adjusted for the effect of the recapitalization that occurred as a result of the reverse acquisition.
	The acquisition of Foundation was based on management’s belief that Foundation’s acquisition and development strategy and operating model will enable the Company to grow by taking advantage of highly-fragmented markets, an increasing demand for short stay surgery and a need by physicians to forge strategic alliances to meet the needs of the evolving healthcare landscape while also shaping the clinical environments in which they practice.
	Simultaneous with and subject to the reverse acquisition, the Company issued 13,333,333 shares of common stock to purchase a $6.0 million participation in the credit facility owed by the Company to Arvest Bank (see Note 5 – Discontinued Operations for more information) and 17,970,295 shares of common stock to Mr. Roy T. Oliver, one of our greater than 5% shareholders and affiliates, for full satisfaction of debt owed to Mr. Oliver totaling $8,136,390. Since the completion of the reverse acquisition was subject to these transactions, they have been recorded as part of the reverse acquisition.
	Since FSA is deemed to be the accounting acquirer, the reverse acquisition was recorded by allocating the purchase price of the acquisition to the assets acquired, including intangible assets and liabilities assumed, from the legacy business of Graymark Healthcare, Inc. (“Graymark”), based on their estimated fair values at the acquisition date. The excess of the cost of the acquisitions over the net amounts assigned to the estimated fair value of the assets acquired, net of liabilities assumed, was recorded as goodwill, none of which is anticipated to be tax deductible.
	The fair value of the total consideration issued in the reverse acquisition amounted to $17.4 million and included $13.4 million for the issuance of the Company’s common stock to FHA, Arvest Bank and Mr. Oliver, $2.0 million for the promissory note issued to FHA and $2.0 million for the debt obligations and liabilities assumed from FHA.
	The final purchase allocation for the reverse acquisition is presented in the table below:
		Graymark
	Cash and cash equivalents	$	68,170
	Accounts receivable		249,333
	Current assets from discontinued operations		1,360,143
	Other current assets		198,976
	Total current assets		1,876,622
		Graymark
	Property and equipment		1,389,169
	Intangible assets		2,733,000
	Goodwill		21,864,781
	Other assets from discontinued operations		1,224,140
	Other assets		252,528
	Total assets acquired		29,340,240
	Liabilities assumed:
	Accounts payable and accrued liabilities		2,899,823
	Short term debt		2,000,000
	Current portion of long-term debt		714,711
	Current liabilities from discontinued operations		7,375,521
	Total current liabilities		12,990,055
	Long-term debt, net of current portion		742,385
	Other liabilities from discontinued operations		305,969
	Other liabilities		1,362,957
	Total liabilities assumed		15,401,366
	Net assets acquired	$	13,938,874
	During the three months ended March 31, 2013, the Company incurred $93,197 in expenses related to the reverse acquisition. The expenses incurred related primarily to legal fees related to the Purchase Agreement and structure of the transaction and professional fees related to the audits of the 2012 and 2011 consolidated financial statements of FSA.
	The amounts of acquisition revenues and earnings included in the Company’s consolidated statements of operations for the three months ended March 31, 2014, and the revenue and earnings of the combined entity had the reverse acquisition date for Graymark been January 1, 2013 are as follows:
				Loss from						Attributable to Foundation
		Revenue		Continuing			Net Loss			Net Loss			Net Loss
				Operations									Per Share
	Actual:
	From 1/1/2014 to 3/31/2014	$	504,943	$	(1,955,672	)	$	(2,459,419	)	$	(2,459,419	)	$	(0.01	)
	Supplemental Pro Forma:
	Three months ending 3/31/2013	$	21,561,851	$	(4,194,248	)	$	(4,139,689	)	$	(3,000,129	)	$	(0.02	)
	The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the acquisition been consummated as of that time, nor is it intended to be a projection of future results.

Discontinued_Operations

Discontinued Operations	3 Months Ended
	Mar. 31, 2014
Discontinued Operations And Disposal Groups [Abstract]	'
Discontinued Operations	'
	Note 5 – Discontinued Operations
	Prior to the reverse acquisition, Graymark committed to a plan to divest of or close certain sleep diagnostic and sleep therapy locations. The decision was based on a combination of the financial performance of the facilities and the shift in focus to the business model of Foundation. As a result of the pending closure or sale of these locations, the related assets, liabilities, results of operations and cash flows were classified as discontinued operations which were acquired by the Company in the reverse acquisition.
	Under the plan, from July 2013 to October 2013, the Company closed or sold 24 sleep diagnostic locations including both IDTF and contracted locations in Georgia, Iowa, Kansas, Missouri, Nevada, Oklahoma and Texas and 5 sleep therapy locations in Iowa, Kansas, Nevada, Oklahoma and Texas.
	As part of the reverse acquisition, the Company acquired the special charge liability of $475,570 related to the estimated closing costs resulting from the plan to sell or close the sleep diagnostic and therapy locations. For the three month period ended March 31, 2014, the activity in the acquired accruals for restructuring charges established for lease termination costs were as follows:
			Lease
			Termination
			Costs
	Balance at December 31, 2013		$	78,235
	Adjustments			151,531
	Cash payments			(32,121	)
	Balance at March 31, 2014		$	197,645
	Adjustments to the special charge liability include changes to estimated settlements or other changes to the liabilities. Additional charges or adjustments may be recorded in future periods dependent upon the Company’s ability to sub-lease or otherwise mitigate future lease costs at closed facilities.
	The operating results of the discontinued sleep diagnostic and therapy locations and the Company’s other discontinued operations for the three month period ended March 31, 2014 are summarized below:
			2014
	Revenues		$	123,729
	Net loss before taxes		$	(503,747	)
	Income tax benefit			191,424
	Net loss from discontinued operations, net of tax		$	(312,323	)
	The balance sheet items for discontinued operations are summarized below:
			March 31,			December 31,
			2014			2013
	Cash and cash equivalents		$	19,108		$	49,252
	Accounts receivable, net of allowances			39,284			222,943
	Inventories			—			1,893
	Other current assets			140,640			244,541
	Total current assets			199,032			518,629
	Fixed assets, net			363,379			426,228
	Other assets			150,000			150,000
	Total noncurrent assets			513,379			576,228
	Total assets		$	712,411		$	1,094,857
	Payables and accrued liabilities		$	1,564,374		$	1,557,771
	Short term debt			3,882,932			3,994,932
	Current portion of long-term debt			60,676			67,994
	Total current liabilities			5,507,982			5,620,697
	Long-term debt			—			9,969
	Total liabilities		$	5,507,982		$	5,630,666
	The Company’s borrowings and capital lease obligations included in discontinued operations are as follows:
			Rate (1)			Maturity		March 31,			December 31,
						Date		2014			2013
	Short-term Debt:
	Senior bank debt			6	%		Apr. 2014	$	3,882,932		$	3,994,932
	Long-term Debt:
	Sleep center notes payable			6	%		Jan. 2015	$	21,000		$	28,723
	Equipment capital leases			8	%		Nov. 2014		39,676			49,389
	Total								60,676			78,112
	Less: Current portion of long-term debt								(60,676	)		(68,143	)
	Long-term debt							$	—		$	9,969
	-1	Effective rate as of March 31, 2014
	At March 31, 2014, future maturities of long-term debt included in discontinued operations were as follows:
	Twelve months ended March 31, 2015		$	60,676
	On July 22, 2013, the Company’s subsidiaries, SDC Holdings, LLC and ApothecaryRx, LLC (collectively the “Borrowers”), the Company and Mr. Stanton Nelson (the “Guarantor” and the Company’s chief executive officer) entered into a Second Amended and Restated Loan Agreement (the “New Loan Agreement”) and an Amended and Restated Promissory Note (the “New Note”) with Arvest Bank. The Company, Borrowers, Guarantor and other guarantors previously entered into the Amended and Restated Loan Agreement dated effective December 17, 2010, as amended by the First Amendment to Loan Agreement dated January 1, 2012, the Second Amendment to Loan Agreement dated effective June 30, 2012, and the Third Amendment to Loan Agreement dated effective October 12, 2012 (the “Prior Agreement”). Under the Prior Agreement, the Company and Borrowers were indebted to Arvest Bank under the Amended and Restated Promissory Note, in the original principal amount of $15,000,000 dated June 30, 2010 and the Second Amended and Restated Promissory Note, in the original principal amount of $30,000,000, dated June 30, 2010 (the “Prior Notes”). Arvest Bank, the Company, the Borrowers and the Guarantor have agreed to restructure the loan evidenced by the Prior Notes and the Prior Agreement. As of March 31, 2014 and December 31, 2013, the outstanding principal amount of the New Note was $9,882,932 and $9,994,932, respectively.
	On July 22, 2013, in conjunction with the New Loan Agreement with Arvest Bank, the Company entered into a Participation Agreement with Arvest Bank in which we purchased a $6,000,000 participation in the New Note from Arvest Bank in exchange for 13,333,333 shares of the Company’s common stock. The Company purchased the participation in the last $6,000,000 of the principal amount due under the Arvest credit facility. The Company’s participation in the note is eliminated against the New Note in the long-term debt table shown above.
	The New Loan Agreement and New Note were entered into on the same date as and in conjunction with the reverse acquisition. As such, the New Note is included in the opening balance sheet in the reverse acquisition accounting (see Note 4 – Reverse Acquisition).
	The New Note is collateralized by substantially all of the assets of the Borrowers and the personal guaranty of the Guarantor which is limited to $2,919,000. The note bears interest at the greater of the prime rate or 6.0% and provided the Borrowers are not in default, the Borrowers are required to make monthly payments of interest only. The entire unpaid principal balance and all accrued and unpaid interest thereon was due and payable on April 30, 2014. Additionally, the New Note is subject to certain financial covenants including a debt service coverage ratio (“DSR”) covenant of not less than 1.25 to 1. Arvest Bank has waived the DSR and other financial covenant requirements through April 30, 2014, which was the maturity date of the New Note. The Company is in the process of extending the maturity date of the New Note and the waiver of financial covenants. Historically, management has been successful in obtaining extensions and waivers of covenant violations, however there is no assurance that Arvest Bank will continue to extend the note or waive the covenant violations. See Note 2 – Basis of Presentation for additional information on management’s plan to refinance its existing debt obligations.

Goodwill_and_Other_Intangibles

Goodwill and Other Intangibles	3 Months Ended
	Mar. 31, 2014
Goodwill And Intangible Assets Disclosure [Abstract]	'
Goodwill and Other Intangibles	'
	Note 6 – Goodwill and Other Intangibles
	Changes in the carrying amount of goodwill are as follows:
		Gross				Accumulated				Net
		Amount				Impairment				Carrying
						Losses				Value
	December 31, 2013	$	23,019,309			$	(22,045,382	)		$	973,927
	March 31, 2014	$	23,019,309			$	(22,045,382	)		$	973,927
	Goodwill and intangible assets with indefinite lives must be tested for impairment at least once a year. Carrying values are compared with fair values, and when the carrying value exceeds the fair value, the carrying value of the impaired asset is reduced to its fair value. The Company tests goodwill for impairment on an annual basis in the fourth quarter or more frequently if management believes indicators of impairment exist. The performance of the test involves a two-step process. The first step of the impairment test involves comparing the fair values of the applicable reporting units with their aggregate carrying values, including goodwill. The Company generally determines the fair value of its reporting units using the income approach methodology of valuation that includes the discounted cash flow method as well as other generally accepted valuation methodologies. If the carrying amount of a reporting unit exceeds the reporting unit’s fair value, the Company performs the second step of the goodwill impairment test to determine the amount of impairment loss. The second step of the goodwill impairment test involves comparing the implied fair value of the affected reporting unit’s goodwill with the carrying value of that goodwill.
	The Company has estimated the goodwill associated with the reverse acquisition to be $21.9 million. The Company then determined the projected cash flows from the continuing operations of the legacy Graymark business were not sufficient to support the recorded goodwill. The Company evaluated the fair value of the goodwill subsequent to the reverse acquisition and determined the acquired goodwill was fully-impaired.
	Changes in the carrying amount of intangible assets during the three months ended March 31, 2014 were as follows:
		Carrying				Accumulated				Net
		Amount				Amortization
	December 31, 2013	$	14,524,500			$	(3,385,879	)		$	11,138,621
	Amortization		—				(513,867	)			(513,867	)
	March 31, 2014	$	14,524,500			$	(3,899,746	)		$	10,624,754
	Intangible assets as of March 31, 2014 and December 31, 2013 include the following:
		Useful		March 31, 2014										December 31,
		Life		Carrying				Accumulated				Net		2013
		(Years)		Value				Amortization						Net
	ASC management contracts	6 – 8		$	3,498,500			$	(1,843,754	)		$	1,654,746	$	1,763,463
	Covenants not to compete	5			2,027,000				(545,094	)			1,481,906		1,583,256
	Physician memberships	7			6,468,000				(1,309,000	)			5,159,000		5,390,000
	Trade name	5			381,000				(52,832	)			328,168		347,218
	Service contracts	10			2,150,000				(149,066	)			2,000,934		2,054,684
	Total			$	14,524,500			$	(3,899,746	)		$	10,624,754	$	11,138,621
	Amortization expense for the three months ended March 31, 2014 and 2013 was $513,867 and $113,242 respectively. Amortization expense for the next five years related to these intangible assets is expected to be as follows:
	Twelve months ended March 31,
	2015	$	2,055,474
	2016		2,055,474
	2017		2,055,474
	2018		1,818,641
	2019		1,174,757

Borrowings_and_Capital_Lease_O

Borrowings and Capital Lease Obligations	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Borrowings and Capital Lease Obligations	'
	Note 7 – Borrowings and Capital Lease Obligations
	The Company’s short-term debt obligations are as follows:
			Rate (1)		March 31,				December 31,
					2014				2013
	Senior Lender:
	Notes payable – working capital		6.5 –7.0%		$	2,803,270			$	2,814,027
	Other Lenders:
	Note payable – S&H Leasing		11.50%			1,865,600				1,865,600
	Note payable – working capital		5.00%			800,000				800,000
	Insurance premium financings		3.0 – 4.8%			652,837				101,135
	Note payable – Medicare cost report		10.10%			61,903				84,065
	Short-term debt				$	6,183,610			$	5,664,827
	-1	Effective rate as of March 31, 2014
	In April 2014, the Company extended the maturity date of two short-term working capital loans from its senior lender. The notes are collateralized by the inventory, accounts receivable, equipment and other assets of one of the Company’s hospital subsidiaries. The notes bear interest at variable rates of prime plus 1.5% and 3.75% with floors of 6.5% and 7%. The Company is required to make monthly payments totaling $15,679 with the balances due at maturity in January 2015 and February 2016. The note that matures in February 2016 is classified as short-term debt because it is due on demand.
	The Company’s long-term debt and capital lease obligations are as follows:
			Rate (1)		Maturity		March 31,				December 31,
					Date		2014				2013
	Senior Lender:
	Line of credit		7.00%		Jun. 2014		$	896,000			$	896,000
	Notes payable – working capital		5.5 – 7.0%		Sep. 2015 –Mar. 2016			3,322,646				3,715,088
	Note payable – equity investments		6.25%		Sept. 2016			2,999,360				3,270,427
	Note payable – management agreements		6.00%		Dec. 2016			591,922				640,466
	Note payable – assumption		6.75%		Jan. 2015			114,270				146,857
	Other Lenders:
	Note payable – preferred interest redemption		10.00%		Jul. 2015			5,100,000				5,100,000
	Notes payable – settlements		5.25 – 8.0%		Dec. 2014 –Jan. 2018			1,020,056				1,189,725
	Note payable – THE		4.6 – 8.0%		Jan. 2015 – Feb. 2016			272,811				311,149
	Notes payable – physician partners		5.25 – 6.5%		May 2014 – Dec. 2014			55,161				103,604
	Notes payable – acquisition		6.00%		Dec. 2014 – Oct. 2015			79,346				99,610
	Capital lease obligations		4.8 – 13.7%		Sep. 2014 – Jul. 2017			2,129,610				2,477,985
	Total							16,581,182				17,950,911
	Less: Current portion of long-term debt							(10,592,445	)			(7,919,179	)
	Long-term debt						$	5,988,737			$	10,031,732
	-1	Effective rate as of March 31, 2014
	In April 2014, the Company extended the maturity date of two working capital loans from its senior lender to March 2016. The notes bear interest at variable rates of prime plus 1.5% with floors of 6.5% and require monthly payments of principal and interest totaling $47,510. The notes are collateralized by the inventory, accounts receivable, equipment and other assets of one of the Company’s hospital subsidiaries. The total principal owed on the notes at March 31, 2014 is $1,389,582.
	The Company has entered into various short-term and long-term notes payable with its senior lender, Legacy Bank (referred to as “Legacy Debt”). As of March 31, 2014 and December 31, 2013, the balance of the Legacy Debt was $10.7 million and $11.5 million, respectively. The Legacy Debt is collateralized by substantially all of the assets of the Company’s subsidiaries, FSA and FSHA, and a portion is personally guaranteed by certain officers of the Company. In conjunction with the Legacy Debt, the Company has agreed to comply with certain financial covenants (as defined and calculated at the FSA and FSHA level) including:
		•		Debt Service Coverage Ratio of 1.05 to 1 and increasing to 1.1 to 1 by December 31, 2013; 1.15 to 1 by March 31, 2014; and 1.2 to 1 by June 30, 2014; and
		•		Minimum Tangible Net Worth (as defined for FSA and FSHA) of $11.1 million increased each quarter (beginning in September 30, 2013 by 50% of FSA’s and FSHA’s net income for the quarter).
	As of March 31, 2014, FSA and FSHA are not in compliance with the Legacy Debt Minimum Tangible Net Worth financial covenant. Management has requested a waiver from Legacy Bank for the covenant violation. Historically, management has been successful in obtaining waivers from the bank for any covenant non-compliance; however there is no assurance that the Company will be able to obtain waivers in the future. Management does not anticipate obtaining a waiver for a period greater than 12 months and it is unlikely that the Company will regain compliance with the Minimum Tangible Net Worth covenant within the next 12 months. As a result, the Legacy Debt has been classified as current in the accompanying consolidated balance sheets as of March 31, 2014. See Note 2 – Basis of Presentation for additional information on management’s plan to refinance its existing debt obligations.
	At March 31, 2014, future maturities of long-term debt were as follows:
	2015		$	10,592,445
	2016			5,587,036
	2017			326,688
	2018			52,562
	2019			22,451
	Thereafter			—

Preferred_Noncontrolling_Inter

Preferred Noncontrolling Interests	3 Months Ended
	Mar. 31, 2014
Noncontrolling Interest [Abstract]	'
Preferred Noncontrolling Interests	'
	Note 8 – Preferred Noncontrolling Interests
	During 2013, the Company’s wholly-owned subsidiary, Foundation Health Enterprises, LLC (“FHE”) completed a private placement offering of $9,135,000. The offering was comprised of 87 units (“FHE Unit” or “preferred noncontrolling interest”). Each FHE Unit was offered at $105,000 and entitled the purchaser to one (1) Class B membership interest in FHE, valued at $100,000, and 10,000 shares of the Company’s common stock, valued at $5,000. The total consideration of $9,135,000 was comprised of $8,700,000 attributable to the preferred noncontrolling interest and $435,000 attributable to the 870,000 shares of the Company’s common stock.
	The FHE Units provide for a cumulative preferred annual return of 9% on the amount allocated to the Class B membership interests. The FHE Units will be redeemed by FHE in four annual installments beginning in July 2014. The first three installments shall be in the amount of $10,000 per FHE Unit and the fourth installment will be in the amount of the unreturned capital contribution and any undistributed preferred distributions. The FHE Units are convertible at the election of the holder at any time prior to the complete redemption into restricted common shares of the Company at a conversion price of $2.00 per share. Since the FHE Units have a redemption feature and a conversion feature which the Company determined to be substantive, the preferred noncontrolling interests has been recorded at the mezzanine level in the accompanying consolidated balance sheets and the corresponding dividends are recorded as a reduction of accumulated deficit.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2014
Commitments And Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Note 9 – Commitments and Contingencies
	Legal claims – The Company is exposed to asserted and unasserted legal claims encountered in the normal course of business, including claims for damages for personal injuries, medical malpractice, breach of contracts, wrongful restriction of or interference with physicians’ staff privileges and employment related claims. In certain of these actions, plaintiffs request payment for damages, including punitive damages that may not be covered by insurance. Management believes that the ultimate resolution of these matters will not have a material adverse effect on the operating results or the financial position of the Company. There were no settlement expenses during the three months ended March 31, 2014 and 2013 related to the Company’s ongoing unasserted legal claims.
	Self-insurance – Effective January 1, 2014, the Company began using a combination of insurance and self-insurance for employee-related healthcare benefits. The self-insurance liability is determined actuarially, based on the actual claims filed and an estimate of incurred but not reported claims. Self-insurance reserves as of March 31, 2014 were $418,246 and are included in accrued liabilities in the accompanying consolidated balance sheets.

Fair_Value_Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	Note 10 – Fair Value Measurements
	Fair value is the price that would be received from the sale of an asset or paid to transfer a liability (i.e., an exit price) in the principal or most advantageous market in an orderly transaction between market participants. In determining fair value, the accounting standards established a three-level hierarchy that distinguishes between (i) market data obtained or developed from independent sources (i.e., observable data inputs) and (ii) a reporting entity’s own data and assumptions that market participants would use in pricing an asset or liability (i.e., unobservable data inputs). Financial assets and financial liabilities measured and reported at fair value are classified in one of the following categories, in order of priority of observability and objectivity of pricing inputs:
		•	Level 1 – Fair value based on quoted prices in active markets for identical assets or liabilities.
		•	Level 2 – Fair value based on significant directly observable data (other than Level 1 quoted prices) or significant indirectly observable data through corroboration with observable market data. Inputs would normally be (i) quoted prices in active markets for similar assets or liabilities, (ii) quoted prices in inactive markets for identical or similar assets or liabilities or (iii) information derived from or corroborated by observable market data.
		•	Level 3 – Fair value based on prices or valuation techniques that require significant unobservable data inputs. Inputs would normally be a reporting entity’s own data and judgments about assumptions that market participants would use in pricing the asset or liability.
	The fair value measurement level for an asset or liability is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques should maximize the use of observable inputs and minimize the use of unobservable inputs.
	Recurring Fair Value Measurements: The carrying value of the Company’s financial assets and financial liabilities is their cost, which may differ from fair value. The carrying value of cash held as demand deposits, money market and certificates of deposit, accounts receivable, short-term borrowings, accounts payable and accrued liabilities approximated their fair value. At March 31, 2014, the fair value of the Company’s long-term debt, including the current portion was determined to be approximately equal to its carrying value.
	Nonrecurring Fair Value Measurements: During the three months ended March 31, 2014, the Company did have any assets or liabilities recorded using nonrecurring fair value measurements.

Real_Estate_Transaction

Real Estate Transaction	3 Months Ended
	Mar. 31, 2014
Real Estate [Abstract]	'
Real Estate Transaction	'
	Note 11 – Real Estate Transaction
	On March 1, 2014, the Company executed a 15 year master lease on the building occupied by the Company’s hospital subsidiary in San Antonio, Texas for an annual rent of $2.3 million with annual escalations of 3%. The current lease income on the underlying sub-lease is approximately $2.1 million per year which includes the rent paid by FBH SA. The master lease is an operating lease. In conjunction with the master lease and certain other agreements with the landlord, the Company received $4.1 million at the time of the lease. Given the disparity between the annual rent expense under the master lease and the rental income of the underlying sub-lease, the cash received at the execution of the lease was deferred and will be recorded on a straight-line basis as a reduction in the rent expense under the master lease.

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	Note 12 – Related Party Transactions
	As of March 31, 2014, the Company had $2.3 million on deposit at Valliance Bank. Valliance Bank is controlled by Mr. Roy T. Oliver, one of our greater than 5% shareholders and affiliates. In addition, the Company is obligated to Valliance Bank under certain notes payable totaling approximately $5.9 million at March 31, 2014 and December 31, 2013. The interest rates on the notes range from 5% to 10%. Non-controlling interests in Valliance Bank are held by Mr. Stanton Nelson, the Company’s chief executive officer and Mr. Joseph Harroz, Jr., a director of the Company. Mr. Nelson and Mr. Harroz also serve as directors of Valliance Bank.
	In October 2013, the Company completed a private placement offering $9,135,000 (see Note 8 – Preferred Noncontrolling Interests for additional information). The offering was comprised of 87 FHE Units. Each FHE Unit was offered at $105,000 and entitled the purchaser to one (1) Class B membership interest in FHE, valued at $100,000, and 10,000 shares of the Company’s common stock, valued at $5,000. Mr. Stanton Nelson, the Company’s chief executive officer, purchased 5 FHE units for $525,000.
	The Company occupies office space subject to a lease agreement with City Place, LLC (“City Place”). Under the lease agreement, the Company pays monthly rent of $17,970 until June 30, 2014; $0.00 from July 1, 2014 to January 31, 2015 and $17,970 from February 1, 2015 to March 31, 2017 plus additional payments for allocable basic expenses of City Place; the lease expires on March 31, 2017. Non-controlling interests in City Place are held by Roy T. Oliver, one of the Company’s greater than 5% shareholders and affiliates. During the three months ended March 31, 2014, the Company incurred approximately $22,000 in lease expense under the terms of the lease.
	As of March 31, 2014 and December 31, 2013, the Company has obligations of $1.4 million that are owed to FHA and certain real estate subsidiaries and affiliates of FHA related to transactions that occurred prior to the Foundation acquisition in July 2013. The amounts owed to FHA and FHA affiliates are included in other liabilities on the accompanying consolidated balance sheets.
	The Company has entered into agreements with certain of its Affiliate ASCs and hospitals to provide management services. As compensation for these services, the surgery centers and hospitals are charged management fees which are either fixed or are based on a percentage of the Affiliates cash collected or the Affiliates net revenue. The percentages range from 2.25% to 6.0%.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	Note 13 – Subsequent Events
	Management evaluated all activity of the Company and concluded that no material subsequent events have occurred, other than those disclosed in the notes to the consolidated financial statements, that would require recognition in the consolidated financial statements or disclosure in the notes to the consolidated financial statements.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Interim Financial Information	'
	Interim Financial Information – The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles for interim financial statements and in accordance with Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2014 are not necessarily indicative of results that may be expected for the year ended December 31, 2014. The consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Form 10-K for the year ended December 31, 2013. The December 31, 2013 consolidated balance sheet was derived from audited financial statements.
Pro forma income information	'
	Pro forma income information – Prior to July 22, 2013, FSA’s and FSHA’s member had elected to have FSA’s and FSHA’s income taxed as an S Corporation under provisions of the Internal Revenue Code and a similar section of the state income tax law. Therefore, taxable income or loss is reported to the individual member for inclusion in its tax returns and no provision for income taxes is included in the Company’s consolidated financial statements for periods prior to July 22, 2013. The pro forma income information provides an adjustment for income tax expense as if FSA and FSHA had been a C Corporation prior to July 22, 2013 at an assumed combined federal and state effective tax rate of 38%, which approximates the calculated statutory tax rates for the periods.
Consolidation	'
	Consolidation – The accompanying consolidated financial statements include the accounts of the Company and its wholly owned, majority owned and controlled subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.
	The Company accounts for its investments in Affiliates in which the Company exhibits significant influence, but not control, in accordance with the equity method of accounting. The Company does not consolidate its equity method investments, but rather measures them at their initial costs and then subsequently adjusts their carrying values through income for their respective shares of the earnings or losses during the period. The Company monitors its investments for other-than-temporary impairment by considering factors such as current economic and market conditions and the operating performance of the companies and records reductions in carrying values when necessary.
Use of estimates	'
	Use of estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
Revenue recognition and accounts receivable	'
	Revenue recognition and accounts receivable – The Company recognizes revenues in the period in which services are performed. Accounts receivable primarily consist of amounts due from third-party payors and patients. The Company’s ability to collect outstanding receivables is critical to its results of operations and cash flows. Amounts the Company receives for treatment of patients covered by governmental programs such as Medicare and Medicaid and other third-party payors such as health maintenance organizations, preferred provider organizations and other private insurers are generally less than the Company’s established billing rates. Additionally, to provide for accounts receivable that could become uncollectible in the future, the Company establishes an allowance for doubtful accounts to reduce the carrying value of such receivables to their estimated net realizable value. Accordingly, the revenues and accounts receivable reported in the Company’s consolidated financial statements are recorded at the net amount expected to be received.
Contractual Discounts and Cost Report Settlements	'
	Contractual Discounts and Cost Report Settlements – The Company derives a significant portion of its revenues from Medicare, Medicaid and other payors that receive discounts from its established billing rates. The Company must estimate the total amount of these discounts to prepare its consolidated financial statements. The Medicare and Medicaid regulations and various managed care contracts under which these discounts must be calculated are complex and are subject to interpretation and adjustment. The Company estimates the allowance for contractual discounts on a payor-specific basis given its interpretation of the applicable regulations or contract terms. These interpretations sometimes result in payments that differ from the Company’s estimates. Additionally, updated regulations and contract renegotiations occur frequently, necessitating regular review and assessment of the estimation process by management. Changes in estimates related to the allowance for contractual discounts affect revenues reported in the Company’s accompanying consolidated statements of operations.
	Cost report settlements under reimbursement agreements with Medicare and Medicaid are estimated and recorded in the period the related services are rendered and are adjusted in future periods as final settlements are determined. There is a reasonable possibility that recorded estimates will change by a material amount in the near term. There was no adjustment for estimated cost report settlements in the three month periods ended March 31, 2014 or 2013. The net cost report settlements due to the Company was approximately $235,000 and $235,000 at March 31, 2014 and December 31, 2013, respectively, and in included in prepaid and other current assets in the accompanying consolidated balance sheets. The Company’s management believes that adequate provisions have been made for adjustments that may result from final determination of amounts earned under these programs.
	Laws and regulations governing Medicare and Medicaid programs are complex and subject to interpretation. The Company believes that it is in compliance with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the Company’s financial statements. Compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties and exclusion from the Medicare and Medicaid programs.
Provision and Allowance for Doubtful Accounts	'
	Provision and Allowance for Doubtful Accounts – To provide for accounts receivable that could become uncollectible in the future, the Company establishes an allowance for doubtful accounts to reduce the carrying value of such receivables to their estimated net realizable value. The primary uncertainty lies with uninsured patient receivables and deductibles, co-payments or other amounts due from individual patients.
	The Company has an established process to determine the adequacy of the allowance for doubtful accounts that relies on a number of analytical tools and benchmarks to arrive at a reasonable allowance. No single statistic or measurement determines the adequacy of the allowance for doubtful accounts. Some of the analytical tools that the Company utilizes include, but are not limited to, the aging of accounts receivable, historical cash collection experience, revenue trends by payor classification, revenue days in accounts receivable, the status of claims submitted to third party payors, reason codes for declined claims and an assessment of the Company’s ability to address the issue and resubmit the claim and whether a patient is on a payment plan and making payments consistent with that plan. Accounts receivable are written off after collection efforts have been followed in accordance with the Company’s policies. During the Company’s normal quarterly review process at March 31, 2014, management determined that a portion of the accounts receivable related to personal injury cases at our FSH SA location had grown to a level requiring it to be analyzed as a distinct payor category. Based on the historical cash collection experience and other analytical measures as noted above, the allowance for doubtful accounts related to the personal injury cases was lowered by $1.0 million.
	Due to the nature of the healthcare industry and the reimbursement environment in which the Company operates, certain estimates are required to record net revenues and accounts receivable at their net realizable values at the time products or services are provided. Inherent in these estimates is the risk that they will have to be revised or updated as additional information becomes available, which could have a material impact on the Company’s operating results and cash flows in subsequent periods. Specifically, the complexity of many third-party billing arrangements and the uncertainty of reimbursement amounts for certain services from certain payors may result in adjustments to amounts originally recorded.
	The patient and their third party insurance provider typically share in the payment for the Company’s products and services. The amount patients are responsible for includes co-payments, deductibles, and amounts not covered due to the provider being out-of-network. Due to uncertainties surrounding deductible levels and the number of out-of-network patients, the Company is not certain of the full amount of patient responsibility at the time of service. The Company estimates amounts due from patients prior to service and generally collects those amounts prior to service. Remaining amounts due from patients are then billed following completion of service.
Cash and cash equivalents	'
	Cash and cash equivalents – The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. Certificates of deposit with original maturities of more than three months are also considered cash equivalents if there are no restrictions on withdrawing funds from the account.
Goodwill and Intangible Assets	'
	Goodwill and Intangible Assets – The Company evaluates goodwill for impairment at least on an annual basis and more frequently if certain indicators are encountered. Goodwill is to be tested at the reporting unit level, defined as an ASC or hospital (referred to as a component), with the fair value of the reporting unit being compared to its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is not considered to be impaired. The Company will complete its annual impairment test in December 2014.
	Intangible assets other than goodwill which include physician membership interests, service contracts and covenants not to compete are amortized over their estimated useful lives using the straight line method. The remaining lives range from five to ten years. The Company evaluates the recoverability of identifiable intangible asset whenever events or changes in circumstances indicate that an intangible asset’s carrying amount may not be recoverable.
Net income (loss) per share	'
	Net income (loss) per share – Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted during the period. Dilutive securities having an anti-dilutive effect on diluted loss per share are excluded from the calculation.
Recently Adopted and Recently Issued Accounting Guidance	'
	Recently Adopted and Recently Issued Accounting Guidance
	Adopted Guidance
	In February 2013, the FASB issued changes to the accounting for obligations resulting from joint and several liability arrangements. These changes require an entity to measure such obligations for which the total amount of the obligation is fixed at the reporting date as the sum of (i) the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors, and (ii) any additional amount the reporting entity expects to pay on behalf of its co-obligors. An entity will also be required to disclose the nature and amount of the obligation as well as other information about those obligations. Examples of obligations subject to these requirements are debt arrangements and settled litigation and judicial rulings. These changes become effective for the Company on January 1, 2014. Management has determined that the adoption of these changes did not have an impact on the Company’s consolidated financial statements, as the Company does not currently have any such arrangements.
	In July 2013, the FASB issued changes to the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. These changes require an entity to present an unrecognized tax benefit as a liability in the financial statements if (i) a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position, or (ii) the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset to settle any additional income taxes that would result from the disallowance of a tax position. Otherwise, an unrecognized tax benefit is required to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. Previously, there was diversity in practice as no explicit guidance existed. These changes become effective for the Company on January 1, 2014. Management has determined that the adoption of these changes did not have a significant impact on the Company’s consolidated financial statements.
	Issued Guidance
	In April 2014, the FASB issued changes to the reporting of discontinued operations and disclosures of disposals of components of an entity. The amendments change the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Additionally, the new guidance requires expanded disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income and expenses of discontinued operations. The amendments are effective prospectively for all disposals (or classifications as held for sale) of components of an entity, and for all businesses that, on acquisition, are classified as held for sale that occur within annual periods beginning on or after December 15, 2014, and interim periods within those years. The Company is currently evaluating the new guidance to determine the impact it may have to its consolidated financial statements.
Prior to reverse acquisition	'
	Prior to the reverse acquisition, Graymark committed to a plan to divest of or close certain sleep diagnostic and sleep therapy locations. The decision was based on a combination of the financial performance of the facilities and the shift in focus to the business model of Foundation. As a result of the pending closure or sale of these locations, the related assets, liabilities, results of operations and cash flows were classified as discontinued operations which were acquired by the Company in the reverse acquisition.
Impairment of goodwill and intangible assets	'
	Goodwill and intangible assets with indefinite lives must be tested for impairment at least once a year. Carrying values are compared with fair values, and when the carrying value exceeds the fair value, the carrying value of the impaired asset is reduced to its fair value. The Company tests goodwill for impairment on an annual basis in the fourth quarter or more frequently if management believes indicators of impairment exist. The performance of the test involves a two-step process. The first step of the impairment test involves comparing the fair values of the applicable reporting units with their aggregate carrying values, including goodwill. The Company generally determines the fair value of its reporting units using the income approach methodology of valuation that includes the discounted cash flow method as well as other generally accepted valuation methodologies. If the carrying amount of a reporting unit exceeds the reporting unit’s fair value, the Company performs the second step of the goodwill impairment test to determine the amount of impairment loss. The second step of the goodwill impairment test involves comparing the implied fair value of the affected reporting unit’s goodwill with the carrying value of that goodwill.
Commitments and Contingencies	'
	The Company is exposed to asserted and unasserted legal claims encountered in the normal course of business, including claims for damages for personal injuries, medical malpractice, breach of contracts, wrongful restriction of or interference with physicians’ staff privileges and employment related claims. In certain of these actions, plaintiffs request payment for damages, including punitive damages that may not be covered by insurance. Management believes that the ultimate resolution of these matters will not have a material adverse effect on the operating results or the financial position of the Company.
Recurring and Nonrecurring Fair Value Measurements	'
	Recurring Fair Value Measurements: The carrying value of the Company’s financial assets and financial liabilities is their cost, which may differ from fair value. The carrying value of cash held as demand deposits, money market and certificates of deposit, accounts receivable, short-term borrowings, accounts payable and accrued liabilities approximated their fair value. At March 31, 2014, the fair value of the Company’s long-term debt, including the current portion was determined to be approximately equal to its carrying value.
	Nonrecurring Fair Value Measurements: During the three months ended March 31, 2014, the Company did have any assets or liabilities recorded using nonrecurring fair value measurements.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Allowance for Doubtful Accounts	'
	The activity in the allowance for doubtful accounts for the three months ending March 31, 2014 follows:
		2014
	Balance at beginning of period	$	4,778,915
	Provisions recognized as reduction in revenues		361,517
	Write-offs, net of recoveries		(2,603,452	)
	Balance at end of period	$	2,536,980

Reverse_Acquisition_Tables

Reverse Acquisition (Tables)	3 Months Ended
	Mar. 31, 2014
Business Combinations [Abstract]	'
Final Purchase Allocation for Reverse Acquisition	'
	The final purchase allocation for the reverse acquisition is presented in the table below:
		Graymark
	Cash and cash equivalents	$	68,170
	Accounts receivable		249,333
	Current assets from discontinued operations		1,360,143
	Other current assets		198,976
	Total current assets		1,876,622
		Graymark
	Property and equipment		1,389,169
	Intangible assets		2,733,000
	Goodwill		21,864,781
	Other assets from discontinued operations		1,224,140
	Other assets		252,528
	Total assets acquired		29,340,240
	Liabilities assumed:
	Accounts payable and accrued liabilities		2,899,823
	Short term debt		2,000,000
	Current portion of long-term debt		714,711
	Current liabilities from discontinued operations		7,375,521
	Total current liabilities		12,990,055
	Long-term debt, net of current portion		742,385
	Other liabilities from discontinued operations		305,969
	Other liabilities		1,362,957
	Total liabilities assumed		15,401,366
	Net assets acquired	$	13,938,874
Acquisition Revenue and Earnings of Combined Entity Reverse Acquisition	'
	The amounts of acquisition revenues and earnings included in the Company’s consolidated statements of operations for the three months ended March 31, 2014, and the revenue and earnings of the combined entity had the reverse acquisition date for Graymark been January 1, 2013 are as follows:
				Loss from						Attributable to Foundation
		Revenue		Continuing			Net Loss			Net Loss			Net Loss
				Operations									Per Share
	Actual:
	From 1/1/2014 to 3/31/2014	$	504,943	$	(1,955,672	)	$	(2,459,419	)	$	(2,459,419	)	$	(0.01	)
	Supplemental Pro Forma:
	Three months ending 3/31/2013	$	21,561,851	$	(4,194,248	)	$	(4,139,689	)	$	(3,000,129	)	$	(0.02	)

Discontinued_Operations_Tables

Discontinued Operations (Tables)	3 Months Ended
	Mar. 31, 2014
Discontinued Operations And Disposal Groups [Abstract]	'
Activity in Acquired Accruals for Restructuring Charges Established for Lease Termination Costs	'
	For the three month period ended March 31, 2014, the activity in the acquired accruals for restructuring charges established for lease termination costs were as follows:
		Lease
		Termination
		Costs
	Balance at December 31, 2013	$	78,235
	Adjustments		151,531
	Cash payments		(32,121	)
	Balance at March 31, 2014	$	197,645
Operating Results and Balance Sheet Items of Discontinued Operations	'
	The operating results of the discontinued sleep diagnostic and therapy locations and the Company’s other discontinued operations for the three month period ended March 31, 2014 are summarized below:
		2014
	Revenues	$	123,729
	Net loss before taxes	$	(503,747	)
	Income tax benefit		191,424
	Net loss from discontinued operations, net of tax	$	(312,323	)
	The balance sheet items for discontinued operations are summarized below:
		March 31,			December 31,
		2014			2013
	Cash and cash equivalents	$	19,108		$	49,252
	Accounts receivable, net of allowances		39,284			222,943
	Inventories		—			1,893
	Other current assets		140,640			244,541
	Total current assets		199,032			518,629
	Fixed assets, net		363,379			426,228
	Other assets		150,000			150,000
	Total noncurrent assets		513,379			576,228
	Total assets	$	712,411		$	1,094,857
	Payables and accrued liabilities	$	1,564,374		$	1,557,771
	Short term debt		3,882,932			3,994,932
	Current portion of long-term debt		60,676			67,994
	Total current liabilities		5,507,982			5,620,697
	Long-term debt		—			9,969
	Total liabilities	$	5,507,982		$	5,630,666

Borrowings_and_Capital_Lease_O1

Borrowings and Capital Lease Obligations (Tables)	3 Months Ended
	Mar. 31, 2014
Discontinued Operations	'
Schedule of Long-Term Debt and Capital Lease Obligations	'
	The Company’s borrowings and capital lease obligations included in discontinued operations are as follows:
			Rate (1)				Maturity				March 31,			December 31,
							Date				2014			2013
	Short-term Debt:
	Senior bank debt			6	%			Apr. 2014			$	3,882,932		$	3,994,932
	Long-term Debt:
	Sleep center notes payable			6	%			Jan. 2015			$	21,000		$	28,723
	Equipment capital leases			8	%			Nov. 2014				39,676			49,389
	Total											60,676			78,112
	Less: Current portion of long-term debt											(60,676	)		(68,143	)
	Long-term debt										$	—		$	9,969
	-1	Effective rate as of March 31, 2014
Future Maturities of Long-Term Debt	'
	At March 31, 2014, future maturities of long-term debt included in discontinued operations were as follows:
	Twelve months ended March 31, 2015		$	60,676
Continuing Operations	'
Schedule of Long-Term Debt and Capital Lease Obligations	'
	The Company’s long-term debt and capital lease obligations are as follows:
			Rate (1)		Maturity		March 31,				December 31,
					Date		2014				2013
	Senior Lender:
	Line of credit		7.00%		Jun. 2014		$	896,000			$	896,000
	Notes payable – working capital		5.5 – 7.0%		Sep. 2015 –Mar. 2016			3,322,646				3,715,088
	Note payable – equity investments		6.25%		Sept. 2016			2,999,360				3,270,427
	Note payable – management agreements		6.00%		Dec. 2016			591,922				640,466
	Note payable – assumption		6.75%		Jan. 2015			114,270				146,857
	Other Lenders:
	Note payable – preferred interest redemption		10.00%		Jul. 2015			5,100,000				5,100,000
	Notes payable – settlements		5.25 – 8.0%		Dec. 2014 –Jan. 2018			1,020,056				1,189,725
	Note payable – THE		4.6 – 8.0%		Jan. 2015 – Feb. 2016			272,811				311,149
	Notes payable – physician partners		5.25 – 6.5%		May 2014 – Dec. 2014			55,161				103,604
	Notes payable – acquisition		6.00%		Dec. 2014 – Oct. 2015			79,346				99,610
	Capital lease obligations		4.8 – 13.7%		Sep. 2014 – Jul. 2017			2,129,610				2,477,985
	Total							16,581,182				17,950,911
	Less: Current portion of long-term debt							(10,592,445	)			(7,919,179	)
	Long-term debt						$	5,988,737			$	10,031,732
	-1	Effective rate as of March 31, 2014
Future Maturities of Long-Term Debt	'
	At March 31, 2014, future maturities of long-term debt were as follows:
	2015		$	10,592,445
	2016			5,587,036
	2017			326,688
	2018			52,562
	2019			22,451
	Thereafter			—
Schedule of Short-Term Debt Obligations	'
	The Company’s short-term debt obligations are as follows:
			Rate (1)		March 31,				December 31,
					2014				2013
	Senior Lender:
	Notes payable – working capital		6.5 –7.0%		$	2,803,270			$	2,814,027
	Other Lenders:
	Note payable – S&H Leasing		11.50%			1,865,600				1,865,600
	Note payable – working capital		5.00%			800,000				800,000
	Insurance premium financings		3.0 – 4.8%			652,837				101,135
	Note payable – Medicare cost report		10.10%			61,903				84,065
	Short-term debt				$	6,183,610			$	5,664,827
	-1	Effective rate as of March 31, 2014

Goodwill_and_Other_Intangibles1

Goodwill and Other Intangibles (Tables)	3 Months Ended
	Mar. 31, 2014
Goodwill And Intangible Assets Disclosure [Abstract]	'
Changes in Carrying Amount of Goodwill	'
	Changes in the carrying amount of goodwill are as follows:
		Gross				Accumulated				Net
		Amount				Impairment				Carrying
						Losses				Value
	December 31, 2013	$	23,019,309			$	(22,045,382	)		$	973,927
	March 31, 2014	$	23,019,309			$	(22,045,382	)		$	973,927
Changes in Carrying Amount of Intangible Assets	'
	Changes in the carrying amount of intangible assets during the three months ended March 31, 2014 were as follows:
		Carrying				Accumulated				Net
		Amount				Amortization
	December 31, 2013	$	14,524,500			$	(3,385,879	)		$	11,138,621
	Amortization		—				(513,867	)			(513,867	)
	March 31, 2014	$	14,524,500			$	(3,899,746	)		$	10,624,754
Intangible Assets	'
	Intangible assets as of March 31, 2014 and December 31, 2013 include the following:
		Useful		March 31, 2014										December 31,
		Life		Carrying				Accumulated				Net		2013
		(Years)		Value				Amortization						Net
	ASC management contracts	6 – 8		$	3,498,500			$	(1,843,754	)		$	1,654,746	$	1,763,463
	Covenants not to compete	5			2,027,000				(545,094	)			1,481,906		1,583,256
	Physician memberships	7			6,468,000				(1,309,000	)			5,159,000		5,390,000
	Trade name	5			381,000				(52,832	)			328,168		347,218
	Service contracts	10			2,150,000				(149,066	)			2,000,934		2,054,684
	Total			$	14,524,500			$	(3,899,746	)		$	10,624,754	$	11,138,621
Amortization Expense for Next Five Years Related to Intangible Assets	'
	Amortization expense for the three months ended March 31, 2014 and 2013 was $513,867 and $113,242 respectively. Amortization expense for the next five years related to these intangible assets is expected to be as follows:
	Twelve months ended March 31,
	2015	$	2,055,474
	2016		2,055,474
	2017		2,055,474
	2018		1,818,641
	2019		1,174,757

Basis_of_Presentation_Addition

Basis of Presentation - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Organization Consolidation And Presentation Of Financial Statements [Abstract]	'	'	'	'
Accumulated deficit	($37,066,821)	'	($35,171,315)	'
Working capital deficiency	16,800,000	'	'	'
Net income (loss) attributable to Foundation Healthcare	-1,702,437	-339,735	'	'
Cash flow from operating activities from continuing operations	1,559,719	-1,375,730	'	'
Cash and cash equivalents	$3,958,742	$1,522,756	$4,212,076	$3,037,067

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	0 Months Ended	3 Months Ended				3 Months Ended
	Jul. 22, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2014
				Prepaid and Other Current Assets	Prepaid and Other Current Assets	Minimum	Maximum
Summary Of Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'
Federal and state effective tax rate	38.00%	'	'	'	'	'	'
Adjustments for cost report settlements	'	$0	$0	'	'	'	'
Cost settlements adjustment amount	'	'	'	235,000	235,000	'	'
Decrease in allowance for doubtful accounts related to personal injury cases	'	$1,000,000	'	'	'	'	'
Estimated useful lives	'	'	'	'	'	'5 years	'10 years

Allowance_for_Doubtful_Account

Allowance for Doubtful Accounts (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Accounting Policies [Abstract]	'	'
Balance at beginning of period	$4,778,915	'
Provisions recognized as reduction in revenues	361,517	636,851
Write-offs, net of recoveries	-2,603,452	'
Balance at end of period	$2,536,980	'

Reverse_Acquisition_Additional

Reverse Acquisition - Additional Information (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013	Jul. 22, 2013	Jul. 22, 2013	Jul. 22, 2013	Jul. 22, 2013	Jul. 22, 2013
				Arvest Loan Participation	Roy T. Oliver	Foundation	Foundation Health Care Affiliates, LLC	FHA, Arvest Bank and Mr. Oliver
Business Acquisition [Line Items]	'	'	'	'	'	'	'	'
Number of shares issued in connection with acquisition	'	'	'	'	'	114,500,000	'	'
Promissory note	'	'	'	'	'	$2,000,000	'	'
Assumed certain liabilities and obligations	'	'	'	'	'	2,000,000	'	'
Common stock issued, shares	171,323,381	163,834,886	'	13,333,333	17,970,295	'	'	'
Common stock issued, amount	17,132	16,383	'	6,000,000	8,136,390	'	'	'
Percentage of ownership in shareholders and affiliates	'	'	'	'	5.00%	'	'	'
Fair value of consideration issued in reverse acquisition	'	'	'	'	'	'	17,400,000	'
Net assets acquired	'	'	'	'	'	'	'	13,400,000
Incurred expenses	'	'	$93,197	'	'	'	'	'

Final_Purchase_Allocation_for_

Final Purchase Allocation for Reverse Acquisition (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Business Acquisition [Line Items]	'	'
Goodwill	$973,927	$973,927
Foundation Health Care Affiliates, LLC | Graymark	'	'
Business Acquisition [Line Items]	'	'
Cash and cash equivalents	68,170	'
Accounts receivable	249,333	'
Current assets from discontinued operations	1,360,143	'
Other current assets	198,976	'
Total current assets	1,876,622	'
Property and equipment	1,389,169	'
Intangible assets	2,733,000	'
Goodwill	21,864,781	'
Other assets from discontinued operations	1,224,140	'
Other assets	252,528	'
Total assets acquired	29,340,240	'
Liabilities assumed:	'	'
Accounts payable and accrued liabilities	2,899,823	'
Short term debt	2,000,000	'
Current portion of long-term debt	714,711	'
Current liabilities from discontinued operations	7,375,521	'
Total current liabilities	12,990,055	'
Long-term debt, net of current portion	742,385	'
Other liabilities from discontinued operations	305,969	'
Other liabilities	1,362,957	'
Total liabilities assumed	15,401,366	'
Net assets acquired	$13,938,874	'

Acquisition_Revenue_and_Earnin

Acquisition Revenue and Earnings of Combined Entity Reverse Acquisition (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Business Acquisition [Line Items]	'	'
Revenue	$22,066,681	$18,653,641
Loss from Continuing Operations	-1,005,193	-1,431,766
Net Loss	-1,317,516	-1,431,766
Net Loss Attributable to Foundation	-1,702,437	-339,735
Net Loss Per Share Attributable to Foundation	($0.01)	$0
Graymark	'	'
Business Acquisition [Line Items]	'	'
Revenue	504,943	'
Loss from Continuing Operations	-1,955,672	'
Net Loss	-2,459,419	'
Net Loss Attributable to Foundation	-2,459,419	'
Net Loss Per Share Attributable to Foundation	($0.01)	'
Supplemental Pro Forma, Revenues	'	21,561,851
Supplemental Pro Forma, Loss from Continuing Operations	'	-4,194,248
Supplemental Pro Forma, Net Loss	'	-4,139,689
Supplemental Pro Forma, Net Loss Attributable to Foundation	'	-3,000,129
Supplemental Pro Forma, Net Loss Per Share Attributable to Foundation	'	($0.02)

Discontinued_Operations_Additi

Discontinued Operations - Additional Information (Detail) (USD $)	3 Months Ended			3 Months Ended		3 Months Ended		0 Months Ended
	Mar. 31, 2014	Jun. 30, 2010	Jun. 30, 2010	Mar. 31, 2014	Dec. 31, 2013	Oct. 31, 2013	Oct. 31, 2013	Jul. 22, 2013
		First Amendment to Loan Agreement	Second Amended and Restated Loan Agreement	Amended and Restated Promissory Note	Amended and Restated Promissory Note	Sleep diagnostic locations	Sleep Therapy Business	Arvest Loan Participation
						Location	Location
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'	'	'	'	'
Number of locations closed or sold	'	'	'	'	'	24	5	'
Amount of special charge liability acquired as part of reverse acquisition	$475,570	'	'	'	'	'	'	'
Debt instrument amount	'	15,000,000	30,000,000	'	'	'	'	6,000,000
Outstanding principal and interest amount	1,389,582	'	'	9,882,932	9,994,932	'	'	'
Exchange of Company`s common stock	'	'	'	'	'	'	'	13,333,333
Guarantor's liability	$2,919,000	'	'	'	'	'	'	'
Interest Floor Rate	'	'	'	6.00%	'	'	'	'
Debt instrument maturity date	'	'	'	30-Apr-14	'	'	'	'
Debt service coverage ratio	'Debt Service Coverage Ratio of 1.05 to 1 and increasing to 1.1 to 1 by December 31, 2013; 1.15 to 1 by March 31, 2014; and 1.2 to 1 by June 30, 2014;	'	'	'1.25 to 1	'	'	'	'

Activity_in_Acquired_Accruals_

Activity in Acquired Accruals for Restructuring Charges Established for Lease Termination Costs (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'
Ending Balance	$475,570
Lease Termination Costs	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'
Beginning Balance	78,235
Adjustments	151,531
Cash payments	-32,121
Ending Balance	$197,645

Operating_Results_and_Balance_

Operating Results and Balance Sheet Items of Discontinued Operations (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Discontinued Operations And Disposal Groups [Abstract]	'	'
Revenues	$123,729	'
Net loss before taxes	-503,747	'
Income tax benefit	191,424	'
Net loss from discontinued operations, net of tax	-312,323	'
Cash and cash equivalents	19,108	49,252
Accounts receivable, net of allowances	39,284	222,943
Inventories	'	1,893
Other current assets	140,640	244,541
Total current assets	199,032	518,629
Fixed assets, net	363,379	426,228
Other assets	150,000	150,000
Total noncurrent assets	513,379	576,228
Total assets	712,411	1,094,857
Payables and accrued liabilities	1,564,374	1,557,771
Short term debt	3,882,932	3,994,932
Current portion of long-term debt	60,676	67,994
Total current liabilities	5,507,982	5,620,697
Long-term debt	'	9,969
Total liabilities	$5,507,982	$5,630,666

LongTerm_Debt_Detail

Long-Term Debt (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]	'	'
Short-term Debt	$6,183,610	$5,664,827
Total borrowings	16,581,182	17,950,911
Less: Current portion of long-term debt	-10,592,445	-7,919,179
Long-term debt	5,988,737	10,031,732
Discontinued Operations	'	'
Debt Instrument [Line Items]	'	'
Total borrowings	60,676	78,112
Less: Current portion of long-term debt	-60,676	-68,143
Long-term debt	'	9,969
Discontinued Operations | Sleep center notes payable	'	'
Debt Instrument [Line Items]	'	'
Debt instrument interest rate	6.00%	'
Debt instrument maturity date	'2015-01	'
Total borrowings	21,000	28,723
Discontinued Operations | Equipment capital leases	'	'
Debt Instrument [Line Items]	'	'
Debt instrument interest rate	8.00%	'
Debt instrument maturity date	'2014-11	'
Total borrowings	39,676	49,389
Discontinued Operations | Senior bank debt	'	'
Debt Instrument [Line Items]	'	'
Debt instrument interest rate	6.00%	'
Debt instrument maturity date	'2014-04	'
Short-term Debt	$3,882,932	$3,994,932

Schedule_of_Future_Maturities_

Schedule of Future Maturities Long-Term Debt (Detail) (USD $)	Mar. 31, 2014
Debt Instrument [Line Items]	'
2015	$10,592,445
Discontinued Operations	'
Debt Instrument [Line Items]	'
2015	$60,676

Changes_in_Carrying_Amount_of_

Changes in Carrying Amount of Goodwill (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Goodwill And Intangible Assets Disclosure [Abstract]	'	'
Goodwill gross amount, beginning balance, gross	$23,019,309	$23,019,309
Goodwill gross amount, ending balance, gross	23,019,309	23,019,309
Goodwill accumulated impairment losses, beginning balance	-22,045,382	-22,045,382
Goodwill accumulated impairment losses, ending balance	-22,045,382	-22,045,382
Goodwill net carrying value, beginning balance	973,927	973,927
Goodwill net carrying value, ending balance	$973,927	$973,927

Goodwill_and_Other_Intangibles2

Goodwill and Other Intangibles - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Goodwill And Intangible Assets Disclosure [Abstract]	'	'
Reverse acquisition	$21,900,000	'
Amortization expense	$513,867	$113,242

Changes_in_Carrying_Amount_of_1

Changes in Carrying Amount of Intangible Assets (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Goodwill And Intangible Assets Disclosure [Abstract]	'	'
Intangible asset carrying amount, beginning balance	$14,524,500	'
Intangible asset carrying amount, Amortization	513,867	113,242
Intangible asset carrying amount, ending balance	14,524,500	'
Intangible asset accumulated amortization, beginning balance	-3,385,879	'
Intangible asset, accumulated amortization	-513,867	'
Intangible asset accumulated amortization, ending balance	-3,899,746	'
Intangible asset beginning balance, net	11,138,621	'
Intangible asset amortization, net	-513,867	-113,242
Intangible asset ending balance, net	$10,624,754	'

Intangible_Assets_Detail

Intangible Assets (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]	'	'
Carrying Amount	$14,524,500	$14,524,500
Accumulated Amortization	-3,899,746	-3,385,879
Net	10,624,754	11,138,621
Minimum	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Life	'5 years	'
Maximum	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Life	'10 years	'
ASC management contracts	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Carrying Amount	3,498,500	'
Accumulated Amortization	-1,843,754	'
Net	1,654,746	1,763,463
ASC management contracts | Minimum	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Life	'6 years	'
ASC management contracts | Maximum	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Life	'8 years	'
Covenants not to compete	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Life	'5 years	'
Carrying Amount	2,027,000	'
Accumulated Amortization	-545,094	'
Net	1,481,906	1,583,256
Physician memberships	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Life	'7 years	'
Carrying Amount	6,468,000	'
Accumulated Amortization	-1,309,000	'
Net	5,159,000	5,390,000
Trade Names	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Life	'5 years	'
Carrying Amount	381,000	'
Accumulated Amortization	-52,832	'
Net	328,168	347,218
Servicing Contracts	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Life	'10 years	'
Carrying Amount	2,150,000	'
Accumulated Amortization	-149,066	'
Net	$2,000,934	$2,054,684

Amortization_Expense_for_Next_

Amortization Expense for Next Five Years Related to Intangible Assets (Detail) (USD $)	Mar. 31, 2014
Debt Disclosure [Abstract]	'
2015	$2,055,474
2016	2,055,474
2017	2,055,474
2018	1,818,641
2019	$1,174,757

Schedule_of_ShortTerm_Debt_Obl

Schedule of Short-Term Debt Obligations (Detail) (USD $)	Mar. 31, 2014		Dec. 31, 2013
Short-term Debt [Line Items]	'		'
Short-term Debt	$6,183,610		$5,664,827
Senior Lender | Working capital note payable	'		'
Short-term Debt [Line Items]	'		'
Short-term Debt	2,803,270		2,814,027
Other Lenders | Working capital note payable	'		'
Short-term Debt [Line Items]	'		'
Debt instrument interest rate	5.00%	[1]	'
Short-term Debt	800,000		800,000
Other Lenders | Note payable - S&H Leasing	'		'
Short-term Debt [Line Items]	'		'
Debt instrument interest rate	11.50%	[1]	'
Short-term Debt	1,865,600		1,865,600
Other Lenders | Insurance premium financings	'		'
Short-term Debt [Line Items]	'		'
Short-term Debt	652,837		101,135
Other Lenders | Note Payable Medicare Cost Report	'		'
Short-term Debt [Line Items]	'		'
Debt instrument interest rate	10.10%	[1]	'
Short-term Debt	$61,903		$84,065
Minimum | Senior Lender | Working capital note payable	'		'
Short-term Debt [Line Items]	'		'
Debt instrument interest rate	6.50%	[1]	'
Minimum | Other Lenders | Insurance premium financings	'		'
Short-term Debt [Line Items]	'		'
Debt instrument interest rate	3.00%	[1]	'
Maximum | Senior Lender | Working capital note payable	'		'
Short-term Debt [Line Items]	'		'
Debt instrument interest rate	7.00%	[1]	'
Maximum | Other Lenders | Insurance premium financings	'		'
Short-term Debt [Line Items]	'		'
Debt instrument interest rate	4.80%	[1]	'
[1]	Effective rate as of March 31, 2014

Borrowings_and_Capital_Lease_O2

Borrowings and Capital Lease Obligations - Additional Information (Detail) (USD $)	3 Months Ended		3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Dec. 31, 2013	Jun. 30, 2014
			Short Term Loan One	Short Term Loan Two	Long Term Debt and Capital Lease Obligations	Legacy Bank	Legacy Bank	Scenario forecast
Extinguishment of Debt [Line Items]	'	'	'	'	'	'	'	'
Spread over prime rate	1.50%	'	1.50%	3.75%	'	'	'	'
Floor variable rate of interest	6.50%	'	6.50%	7.00%	'	'	'	'
Debt instrument maturity date	'	'	31-Jan-15	29-Feb-16	'	'	'	'
Monthly principal and interest payments	$15,679	'	'	'	$47,510	'	'	'
Legacy Debt	'	'	'	'	'	10,700,000	11,500,000	'
Principal amount owed on note	1,389,582	'	'	'	'	'	'	'
Debt service coverage ratio description	'Debt Service Coverage Ratio of 1.05 to 1 and increasing to 1.1 to 1 by December 31, 2013; 1.15 to 1 by March 31, 2014; and 1.2 to 1 by June 30, 2014;	'	'	'	'	'	'	'
Debt service coverage ratio	'	105.00%	'	'	'	'	'	'
Changes in debt service coverage ratio	115.00%	110.00%	'	'	'	'	'	120.00%
Minimum Tangible Net Worth	'	'	'	'	'	$11,100,000	'	'
Percentage of minimum tangible net worth	'	'	'	'	'	50.00%	'	'
Maximum anticipating waiver period	'12 months	'	'	'	'	'	'	'

Schedule_of_LongTerm_Debt_and_

Schedule of Long-Term Debt and Capital Lease Obligations (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014		Dec. 31, 2013
Long Term Debt [Line Items]	'		'
Long-term debt	$16,581,182		$17,950,911
Less: Current portion of long-term debt	-10,592,445		-7,919,179
Long-term debt	5,988,737		10,031,732
Capital lease obligations	'		'
Long Term Debt [Line Items]	'		'
Long-term debt	2,129,610		2,477,985
Senior Lender | Line of credit	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	7.00%	[1]	'
Debt instrument maturity date	'2014-06		'
Long-term debt	896,000		896,000
Senior Lender | Working capital note payable	'		'
Long Term Debt [Line Items]	'		'
Long-term debt	3,322,646		3,715,088
Senior Lender | Note payable - equity investments	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	6.25%	[1]	'
Debt instrument maturity date	'2016-09		'
Long-term debt	2,999,360		3,270,427
Senior Lender | Note payable - management agreements	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	6.00%	[1]	'
Debt instrument maturity date	'2016-12		'
Long-term debt	591,922		640,466
Senior Lender | Note payable - assumption	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	6.75%	[1]	'
Debt instrument maturity date	'2015-01		'
Long-term debt	114,270		146,857
Other Lenders | Note payable - preferred interest redemption	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	10.00%	[1]	'
Debt instrument maturity date	'2015-07		'
Long-term debt	5,100,000		5,100,000
Other Lenders | Notes payable - settlements	'		'
Long Term Debt [Line Items]	'		'
Long-term debt	1,020,056		1,189,725
Other Lenders | Notes payable - THE	'		'
Long Term Debt [Line Items]	'		'
Long-term debt	272,811		311,149
Other Lenders | Notes payable - physician partners	'		'
Long Term Debt [Line Items]	'		'
Long-term debt	55,161		103,604
Other Lenders | Notes payable - acquisition	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	6.00%	[1]	'
Long-term debt	$79,346		$99,610
Minimum | Capital lease obligations	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	4.80%	[1]	'
Debt instrument maturity date	'2014-09		'
Minimum | Senior Lender | Working capital note payable	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	5.50%	[1]	'
Debt instrument maturity date	'2015-09		'
Minimum | Other Lenders | Notes payable - settlements	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	5.25%	[1]	'
Debt instrument maturity date	'2014-12		'
Minimum | Other Lenders | Notes payable - THE	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	4.60%	[1]	'
Debt instrument maturity date	'2015-01		'
Minimum | Other Lenders | Notes payable - physician partners	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	5.25%	[1]	'
Debt instrument maturity date	'2014-05		'
Minimum | Other Lenders | Notes payable - acquisition	'		'
Long Term Debt [Line Items]	'		'
Debt instrument maturity date	'2014-12		'
Maximum | Capital lease obligations	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	13.70%	[1]	'
Debt instrument maturity date	'2017-06		'
Maximum | Senior Lender | Working capital note payable	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	7.00%	[1]	'
Debt instrument maturity date	'2016-03		'
Maximum | Other Lenders | Notes payable - settlements	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	8.00%	[1]	'
Debt instrument maturity date	'2018-01		'
Maximum | Other Lenders | Notes payable - THE	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	8.00%	[1]	'
Debt instrument maturity date	'2016-02		'
Maximum | Other Lenders | Notes payable - physician partners	'		'
Long Term Debt [Line Items]	'		'
Debt instrument interest rate	6.50%	[1]	'
Debt instrument maturity date	'2014-12		'
Maximum | Other Lenders | Notes payable - acquisition	'		'
Long Term Debt [Line Items]	'		'
Debt instrument maturity date	'2015-10		'
[1]	Effective rate as of March 31, 2014

Future_Maturities_LongTerm_Deb

Future Maturities Long-Term Debt (Detail) (USD $)	Mar. 31, 2014
Discontinued Operations And Disposal Groups [Abstract]	'
2015	$10,592,445
2016	5,587,036
2017	326,688
2018	52,562
2019	22,451
Thereafter	'

Preferred_Noncontrolling_Inter1

Preferred Noncontrolling Interests - Additional Information (Detail) (USD $)	1 Months Ended	3 Months Ended	12 Months Ended
	Oct. 31, 2013	Mar. 31, 2014	Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]	'	'	'
Common stock value	'	$17,132	$16,383
Total consideration	'	'	9,135,000
Amount of unreturned capital contribution and undistributed preferred distributions	'	10,000	'
Conversion price per share	'	$2	'
Common Stock	'	'	'
Schedule of Equity Method Investments [Line Items]	'	'	'
Total consideration	'	'	435,000
Number of shares sold	'	'	870,000
Foundation Health Enterprises LLC	'	'	'
Schedule of Equity Method Investments [Line Items]	'	'	'
Offering cost	100,000	'	100,000
Number offering units	5	'	'
Common stock issued	10,000	'	10,000
Common stock value	5,000	'	5,000
Total consideration	'	'	8,700,000
Cumulative preferred annual return	'	9.00%	'
Foundation Health Enterprises LLC | Class B member interests	'	'	'
Schedule of Equity Method Investments [Line Items]	'	'	'
Offering cost	105,000	'	105,000
Number offering units	87	'	87
Foundation Health Enterprises LLC | Private placement	'	'	'
Schedule of Equity Method Investments [Line Items]	'	'	'
Offering cost	$9,135,000	'	$9,135,000

Commitments_and_Contingencies_

Commitments and Contingencies - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Commitments And Contingencies Disclosure [Abstract]	'	'
Legal claims settlement expenses	$0	$0
Self Insurance Reserves	$418,246	'

Real_Estate_Transaction_Additi

Real Estate Transaction - Additional Information (Detail) (San Antonio Texas, USD $)	0 Months Ended
In Millions, unless otherwise specified	Mar. 01, 2014
San Antonio Texas	'
Real Estate Properties [Line Items]	'
Operating Leases, Term of Contract	'15 years
Annual rental payments	$2.30
Percentage of annual lease escalations	3.00%
Income on underlying sub-lease	2.1
Cash received	$4.10

Related_Party_Transactions_Add

Related Party Transactions - Additional Information (Detail) (USD $)

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Oct. 31, 2013

Dec. 31, 2013

Oct. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Oct. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Minimum

Maximum

Foundation Health Enterprises LLC

Foundation Health Enterprises LLC

Foundation Health Enterprises LLC

Foundation Health Enterprises LLC

Foundation Health Enterprises LLC

Foundation Health Enterprises LLC

Notes Payable to Banks

Notes Payable to Banks

Shareholders And Affiliates

Shareholders And Affiliates

City Place

Class B member interests

Class B member interests

Private placement

Private placement

Minimum

Maximum

Related Party Transaction [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related party deposit

$2,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notes payable

'

'

'

'

'

'

'

'

'

'

5,900,000

5,900,000

'

'

'

Interest rates on the notes

'

'

'

'

'

'

'

'

'

'

'

'

5.00%

10.00%

'

Offering cost

'

'

'

'

100,000

100,000

105,000

105,000

9,135,000

9,135,000

'

'

'

'

'

Number offering units

'

'

'

'

5

'

87

87

'

'

'

'

'

'

'

Common stock issued

'

'

'

'

10,000

10,000

'

'

'

'

'

'

'

'

'

Common stock value

17,132

16,383

'

'

5,000

5,000

'

'

'

'

'

'

'

'

'

Amount of Purchase by CEO

'

'

'

'

525,000

'

'

'

'

'

'

'

'

'

'

Lease agreement monthly rent description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'The Company pays monthly rent of $17,970 until June 30, 2014; $0.00 from July 1, 2014 to January 31, 2015 and $17,970 from February 1, 2015 to March 31, 2017 plus additional payments for allocable basic expenses of City Place

Lease expiration date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

31-Mar-17

Lease expense

'

'

'

'

'

'

'

'

'

'

'

'

'

'

22,000

Obligations owed to FHA and other affiliates

$1,400,000

$1,400,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Management fee Percentages range

'

'

2.25%

6.00%

'

'

'

'

'

'

'

'

'

'

'

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail) (Subsequent Events)	0 Months Ended
	12-May-14
Minimum	'
Subsequent Event [Line Items]	'
1 for 10 reverse stock split	'1
Maximum	'
Subsequent Event [Line Items]	'
1 for 10 reverse stock split	'10